Vice President & General Managet South Europe@PTC Therapeutics, Inc.
Verified
Riccardo Ena serves as the Vice President & General Manager for South Europe at PTC Therapeutics, Inc., where he spearheads strategic initiatives to drive market growth and enhance patient access to innovative therapies. With over 15 years of experience in the biopharmaceutical industry, Riccardo has successfully led cross-functional teams to achieve significant revenue milestones and fostered partnerships with key stakeholders across the region. His leadership style is characterized by a strong focus on collaboration and a commitment to advancing healthcare solutions that improve patient outcomes. Riccardo holds a Master’s degree in Pharmaceutical Sciences and is passionate about mentoring emerging leaders in the industry.More...
Ala Tocarciuc
CEO@Almeda Pharmaceuticals AG
Verified
Ala Tocarciuc is a seasoned executive and accomplished professional in the pharmaceutical industry, currently serving as the CEO of Almeda Pharmaceuticals AG. With a career spanning over two decades, Ala has demonstrated exceptional leadership and strategic planning skills, guiding the company towards significant growth and profitability. In her role, she has been instrumental in developing and implementing innovative strategies, managing regulatory affairs, leading product development, and securing partnerships.
Ala's expertise lies in the areas of pharmaceutical operations, business development, and regulatory compliance. Her vision and dedication have been instrumental in transforming Almeda Pharmaceuticals AG into a leading player in the pharmaceutical industry. Prior to her role at Almeda, she held various leadership positions in other prominent pharmaceutical companies, gaining valuable industry experience.
Ala holds a degree in Pharmacy, further solidifying her understanding of the pharmaceutical industry. She is known for her strong work ethic, effective management style, and commitment to excellence. Her leadership continues to drive Almeda Pharmaceuticals AG towards new developments.More...